Eric Pietras
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cells | 36 | 2025 | 381 | 10.270 |
Why?
| Hematopoiesis | 15 | 2025 | 185 | 3.580 |
Why?
| Bone Marrow | 10 | 2024 | 267 | 1.960 |
Why?
| Stem Cell Niche | 8 | 2025 | 51 | 1.710 |
Why?
| Dioxygenases | 3 | 2022 | 29 | 1.640 |
Why?
| Neoplastic Stem Cells | 5 | 2024 | 387 | 1.420 |
Why?
| Inflammation | 13 | 2025 | 2721 | 1.420 |
Why?
| Myelodysplastic Syndromes | 4 | 2024 | 129 | 1.310 |
Why?
| Stress, Physiological | 3 | 2021 | 416 | 1.200 |
Why?
| Proto-Oncogene Proteins | 5 | 2022 | 645 | 1.150 |
Why?
| Mice | 42 | 2025 | 16832 | 1.090 |
Why?
| Interferon Type I | 5 | 2014 | 140 | 1.060 |
Why?
| Cell Proliferation | 9 | 2021 | 2381 | 1.060 |
Why?
| Leukemia | 4 | 2022 | 229 | 1.030 |
Why?
| Cell Cycle | 5 | 2021 | 587 | 1.000 |
Why?
| Trans-Activators | 3 | 2022 | 387 | 0.940 |
Why?
| Cell Differentiation | 12 | 2025 | 1896 | 0.900 |
Why?
| Animals | 54 | 2025 | 35076 | 0.880 |
Why?
| Fecal Microbiota Transplantation | 1 | 2023 | 18 | 0.830 |
Why?
| Leukemia, Myeloid | 1 | 2022 | 45 | 0.800 |
Why?
| Multipotent Stem Cells | 3 | 2021 | 19 | 0.770 |
Why?
| Signal Transduction | 16 | 2025 | 4930 | 0.760 |
Why?
| Cell Lineage | 4 | 2021 | 336 | 0.760 |
Why?
| Leukemia, Myeloid, Acute | 3 | 2024 | 594 | 0.720 |
Why?
| Epigenesis, Genetic | 3 | 2024 | 620 | 0.710 |
Why?
| Oxidative Phosphorylation | 2 | 2025 | 186 | 0.710 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2022 | 1210 | 0.690 |
Why?
| Endothelial Protein C Receptor | 1 | 2019 | 5 | 0.680 |
Why?
| Interleukin-1 | 4 | 2023 | 973 | 0.680 |
Why?
| Antigens, CD34 | 1 | 2019 | 92 | 0.660 |
Why?
| Flow Cytometry | 5 | 2021 | 1158 | 0.660 |
Why?
| Hematologic Diseases | 2 | 2023 | 62 | 0.660 |
Why?
| Mice, Inbred C57BL | 17 | 2025 | 5365 | 0.620 |
Why?
| Stem Cell Factor | 1 | 2018 | 15 | 0.600 |
Why?
| DNA-Binding Proteins | 4 | 2022 | 1433 | 0.590 |
Why?
| Macrophages | 3 | 2024 | 1482 | 0.580 |
Why?
| Arthritis, Experimental | 1 | 2019 | 128 | 0.570 |
Why?
| Health | 1 | 2017 | 74 | 0.550 |
Why?
| Disease | 1 | 2017 | 95 | 0.530 |
Why?
| Mutation | 10 | 2025 | 3723 | 0.510 |
Why?
| Autoimmune Diseases | 1 | 2019 | 426 | 0.490 |
Why?
| Immunity, Innate | 6 | 2023 | 814 | 0.480 |
Why?
| Regeneration | 3 | 2025 | 179 | 0.470 |
Why?
| Virus Diseases | 2 | 2008 | 208 | 0.470 |
Why?
| Monocytes | 2 | 2022 | 556 | 0.450 |
Why?
| Hematopoietic Stem Cell Transplantation | 3 | 2021 | 578 | 0.450 |
Why?
| Cytokines | 7 | 2020 | 2016 | 0.450 |
Why?
| HMGA2 Protein | 1 | 2013 | 9 | 0.430 |
Why?
| Myeloid Cells | 3 | 2025 | 142 | 0.410 |
Why?
| Inflammation Mediators | 2 | 2020 | 509 | 0.400 |
Why?
| Proto-Oncogene Proteins c-ets | 2 | 2022 | 53 | 0.370 |
Why?
| Repressor Proteins | 3 | 2025 | 402 | 0.370 |
Why?
| Receptors, CCR2 | 1 | 2011 | 39 | 0.360 |
Why?
| Receptors, Interferon | 1 | 2011 | 50 | 0.360 |
Why?
| Myeloid Differentiation Factor 88 | 2 | 2011 | 101 | 0.360 |
Why?
| Aging | 7 | 2025 | 1785 | 0.360 |
Why?
| Francisella tularensis | 1 | 2011 | 30 | 0.360 |
Why?
| Germ-Line Mutation | 2 | 2022 | 140 | 0.350 |
Why?
| Phosphoproteins | 3 | 2020 | 333 | 0.350 |
Why?
| DNA | 1 | 2017 | 1412 | 0.340 |
Why?
| Arthritis, Rheumatoid | 1 | 2019 | 1115 | 0.340 |
Why?
| Gene Expression | 5 | 2021 | 1487 | 0.330 |
Why?
| Neutrophils | 6 | 2025 | 1209 | 0.330 |
Why?
| Neoplasms | 3 | 2022 | 2467 | 0.330 |
Why?
| RNA Splicing Factors | 2 | 2020 | 51 | 0.330 |
Why?
| Host-Pathogen Interactions | 2 | 2021 | 349 | 0.330 |
Why?
| Disease Models, Animal | 5 | 2025 | 4044 | 0.320 |
Why?
| Mitochondria | 5 | 2025 | 857 | 0.320 |
Why?
| Humans | 39 | 2025 | 130305 | 0.310 |
Why?
| TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 2 | 0.310 |
Why?
| Cell Cycle Proteins | 2 | 2011 | 585 | 0.310 |
Why?
| Viruses | 2 | 2008 | 99 | 0.300 |
Why?
| Stem Cells | 3 | 2022 | 585 | 0.290 |
Why?
| Homeostasis | 2 | 2021 | 613 | 0.290 |
Why?
| Mice, Transgenic | 5 | 2023 | 2107 | 0.290 |
Why?
| Immunity | 1 | 2008 | 137 | 0.280 |
Why?
| Mitochondrial Proteins | 2 | 2008 | 240 | 0.270 |
Why?
| Reactive Oxygen Species | 2 | 2020 | 587 | 0.270 |
Why?
| MicroRNAs | 1 | 2013 | 680 | 0.270 |
Why?
| Interleukin-1beta | 3 | 2021 | 378 | 0.260 |
Why?
| Diet, Western | 2 | 2023 | 79 | 0.240 |
Why?
| Glycolysis | 2 | 2024 | 299 | 0.240 |
Why?
| Receptors, Colony-Stimulating Factor | 1 | 2025 | 6 | 0.240 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 31 | 0.240 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2025 | 66 | 0.240 |
Why?
| Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 23 | 0.240 |
Why?
| Semaphorins | 1 | 2025 | 25 | 0.230 |
Why?
| Bacterial Infections | 1 | 2006 | 236 | 0.220 |
Why?
| Splicing Factor U2AF | 2 | 2023 | 16 | 0.210 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2022 | 163 | 0.210 |
Why?
| B-Lymphocytes | 3 | 2022 | 822 | 0.210 |
Why?
| Interferon Regulatory Factors | 2 | 2020 | 33 | 0.210 |
Why?
| Transcriptional Activation | 1 | 2025 | 363 | 0.210 |
Why?
| Liver | 2 | 2024 | 1846 | 0.200 |
Why?
| fas Receptor | 4 | 2008 | 96 | 0.200 |
Why?
| Apoptosis | 6 | 2025 | 2519 | 0.200 |
Why?
| Spliceosomes | 2 | 2020 | 44 | 0.200 |
Why?
| Leukocytes | 1 | 2024 | 303 | 0.200 |
Why?
| Cholinergic Agents | 1 | 2022 | 15 | 0.200 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 89 | 0.200 |
Why?
| Mice, Knockout | 6 | 2025 | 2811 | 0.190 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2024 | 252 | 0.190 |
Why?
| Up-Regulation | 3 | 2021 | 856 | 0.190 |
Why?
| Receptors, Notch | 2 | 2020 | 87 | 0.190 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 37 | 0.190 |
Why?
| Cell Transformation, Neoplastic | 2 | 2022 | 328 | 0.180 |
Why?
| DNA Damage | 2 | 2021 | 379 | 0.180 |
Why?
| Myelopoiesis | 2 | 2018 | 7 | 0.180 |
Why?
| Clone Cells | 1 | 2021 | 258 | 0.180 |
Why?
| Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 15 | 0.180 |
Why?
| Carcinogenesis | 1 | 2022 | 210 | 0.180 |
Why?
| Bone Marrow Diseases | 1 | 2020 | 19 | 0.180 |
Why?
| Melanoma, Experimental | 1 | 2021 | 111 | 0.170 |
Why?
| Drug Therapy | 1 | 2020 | 77 | 0.170 |
Why?
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 64 | 0.170 |
Why?
| Cellular Reprogramming | 3 | 2017 | 96 | 0.170 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 155 | 0.160 |
Why?
| Staphylococcus aureus | 3 | 2010 | 431 | 0.160 |
Why?
| Bacteria | 1 | 2006 | 815 | 0.160 |
Why?
| Serine-Arginine Splicing Factors | 1 | 2019 | 24 | 0.160 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 284 | 0.160 |
Why?
| Histone Deacetylases | 1 | 2020 | 211 | 0.150 |
Why?
| Darkness | 1 | 2018 | 25 | 0.150 |
Why?
| Autoimmunity | 1 | 2024 | 867 | 0.150 |
Why?
| Thrombocytopenia | 1 | 2020 | 188 | 0.150 |
Why?
| Wnt Signaling Pathway | 1 | 2020 | 169 | 0.150 |
Why?
| Interferon Inducers | 1 | 2018 | 7 | 0.150 |
Why?
| Staphylococcal Skin Infections | 2 | 2010 | 34 | 0.150 |
Why?
| Poly I-C | 1 | 2018 | 63 | 0.140 |
Why?
| Cells, Cultured | 5 | 2021 | 4106 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2021 | 430 | 0.140 |
Why?
| Models, Biological | 3 | 2015 | 1716 | 0.140 |
Why?
| Anti-Inflammatory Agents | 1 | 2021 | 475 | 0.140 |
Why?
| Granulocyte-Macrophage Progenitor Cells | 1 | 2017 | 4 | 0.140 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 362 | 0.140 |
Why?
| Drug Resistance, Neoplasm | 2 | 2020 | 755 | 0.140 |
Why?
| Cell Self Renewal | 1 | 2017 | 55 | 0.140 |
Why?
| Intervertebral Disc | 1 | 2017 | 39 | 0.130 |
Why?
| Neutrophil Infiltration | 2 | 2007 | 102 | 0.130 |
Why?
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 4 | 0.130 |
Why?
| Heart Diseases | 1 | 2020 | 358 | 0.130 |
Why?
| Antineoplastic Agents | 4 | 2020 | 2078 | 0.130 |
Why?
| Blood Platelets | 1 | 2019 | 373 | 0.130 |
Why?
| Thrombosis | 1 | 2019 | 337 | 0.130 |
Why?
| Lymphoid Progenitor Cells | 1 | 2015 | 11 | 0.120 |
Why?
| Myeloid Progenitor Cells | 1 | 2015 | 17 | 0.120 |
Why?
| RNA Splicing | 3 | 2023 | 262 | 0.120 |
Why?
| Bone Marrow Transplantation | 1 | 2016 | 271 | 0.120 |
Why?
| Mice, Congenic | 1 | 2014 | 22 | 0.110 |
Why?
| Cell Division | 1 | 2016 | 802 | 0.110 |
Why?
| Resting Phase, Cell Cycle | 1 | 2014 | 15 | 0.110 |
Why?
| Primary Myelofibrosis | 1 | 2013 | 9 | 0.110 |
Why?
| Cell Cycle Checkpoints | 1 | 2014 | 96 | 0.110 |
Why?
| Myeloproliferative Disorders | 1 | 2013 | 26 | 0.110 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2006 | 398 | 0.100 |
Why?
| Cellular Senescence | 1 | 2014 | 177 | 0.100 |
Why?
| Endothelial Cells | 1 | 2018 | 744 | 0.100 |
Why?
| DNA Replication | 1 | 2014 | 228 | 0.100 |
Why?
| Primates | 2 | 2024 | 121 | 0.100 |
Why?
| TNF Receptor-Associated Factor 3 | 3 | 2007 | 5 | 0.100 |
Why?
| Cell Survival | 2 | 2014 | 1098 | 0.100 |
Why?
| Transcription Factors | 2 | 2018 | 1649 | 0.090 |
Why?
| Embryo, Mammalian | 1 | 2011 | 227 | 0.090 |
Why?
| Tularemia | 1 | 2011 | 28 | 0.090 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 111 | 0.090 |
Why?
| Chemokine CCL2 | 1 | 2011 | 124 | 0.090 |
Why?
| Megakaryocytes | 2 | 2020 | 32 | 0.080 |
Why?
| RNA-Binding Proteins | 1 | 2013 | 388 | 0.080 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2014 | 513 | 0.080 |
Why?
| Interleukin-17 | 1 | 2010 | 108 | 0.080 |
Why?
| Gene Deletion | 1 | 2011 | 377 | 0.080 |
Why?
| Spleen | 1 | 2011 | 520 | 0.080 |
Why?
| Male | 10 | 2025 | 63748 | 0.080 |
Why?
| Receptors, Interleukin-1 | 2 | 2007 | 225 | 0.080 |
Why?
| Cell Line | 5 | 2021 | 2786 | 0.080 |
Why?
| RNA Viruses | 1 | 2008 | 33 | 0.070 |
Why?
| Interferon Regulatory Factor-3 | 1 | 2007 | 17 | 0.070 |
Why?
| Dinucleoside Phosphates | 1 | 2007 | 28 | 0.070 |
Why?
| Interleukin-6 | 1 | 2011 | 730 | 0.070 |
Why?
| PTEN Phosphohydrolase | 1 | 2008 | 158 | 0.070 |
Why?
| Endopeptidases | 1 | 2007 | 85 | 0.070 |
Why?
| Skin | 2 | 2010 | 742 | 0.070 |
Why?
| Caspases | 2 | 2005 | 249 | 0.070 |
Why?
| Biomarkers | 1 | 2018 | 3923 | 0.070 |
Why?
| RNA, Double-Stranded | 1 | 2006 | 48 | 0.060 |
Why?
| Antibody Formation | 1 | 2007 | 287 | 0.060 |
Why?
| Lipopolysaccharides | 2 | 2019 | 884 | 0.060 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 476 | 0.060 |
Why?
| Toll-Like Receptors | 1 | 2006 | 182 | 0.060 |
Why?
| Receptor, Notch1 | 1 | 2025 | 63 | 0.060 |
Why?
| Listeria monocytogenes | 1 | 2006 | 123 | 0.060 |
Why?
| Organophosphorus Compounds | 1 | 2025 | 78 | 0.060 |
Why?
| Female | 7 | 2023 | 68842 | 0.050 |
Why?
| Bone Marrow Cells | 3 | 2011 | 300 | 0.050 |
Why?
| Chemotaxis | 1 | 2023 | 130 | 0.050 |
Why?
| Staphylococcal Infections | 1 | 2007 | 389 | 0.050 |
Why?
| Neoplasm Invasiveness | 1 | 2004 | 484 | 0.050 |
Why?
| Thrombopoiesis | 1 | 2022 | 8 | 0.050 |
Why?
| RNA, Viral | 1 | 2006 | 624 | 0.050 |
Why?
| Immunophenotyping | 1 | 2024 | 313 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 3 | 2008 | 183 | 0.050 |
Why?
| Macaca mulatta | 1 | 2022 | 154 | 0.050 |
Why?
| Germ Cells | 1 | 2022 | 64 | 0.050 |
Why?
| Mice, SCID | 1 | 2022 | 349 | 0.050 |
Why?
| Time-Lapse Imaging | 1 | 2021 | 19 | 0.050 |
Why?
| Leukemia, Myelomonocytic, Acute | 1 | 2021 | 7 | 0.050 |
Why?
| Gene Expression Profiling | 2 | 2020 | 1714 | 0.050 |
Why?
| Candidiasis | 1 | 2021 | 57 | 0.050 |
Why?
| Mice, Inbred NOD | 1 | 2022 | 586 | 0.040 |
Why?
| Microscopy, Fluorescence | 1 | 2021 | 405 | 0.040 |
Why?
| DNA Methylation | 1 | 2025 | 610 | 0.040 |
Why?
| Cell Movement | 1 | 2004 | 948 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 962 | 0.040 |
Why?
| Adoptive Transfer | 1 | 2020 | 217 | 0.040 |
Why?
| Fetus | 1 | 2024 | 768 | 0.040 |
Why?
| NF-kappa B p50 Subunit | 1 | 2019 | 22 | 0.040 |
Why?
| K562 Cells | 1 | 2019 | 82 | 0.040 |
Why?
| RAW 264.7 Cells | 1 | 2019 | 49 | 0.040 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 82 | 0.040 |
Why?
| Antigens, CD | 1 | 2021 | 483 | 0.040 |
Why?
| Platelet Activation | 1 | 2019 | 85 | 0.040 |
Why?
| Protein Transport | 1 | 2020 | 429 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2019 | 111 | 0.040 |
Why?
| HEK293 Cells | 1 | 2021 | 686 | 0.040 |
Why?
| Lymphopoiesis | 1 | 2018 | 26 | 0.040 |
Why?
| Mice, 129 Strain | 1 | 2018 | 82 | 0.040 |
Why?
| Cohort Studies | 2 | 2020 | 5431 | 0.040 |
Why?
| Fluorouracil | 1 | 2019 | 201 | 0.040 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 290 | 0.040 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2021 | 381 | 0.040 |
Why?
| Protein Isoforms | 1 | 2019 | 379 | 0.040 |
Why?
| NF-kappa B | 3 | 2007 | 691 | 0.040 |
Why?
| Granulocytes | 1 | 2017 | 79 | 0.030 |
Why?
| Mice, Mutant Strains | 2 | 2008 | 295 | 0.030 |
Why?
| Molecular Imaging | 1 | 2017 | 55 | 0.030 |
Why?
| T-Lymphocytes | 2 | 2018 | 1928 | 0.030 |
Why?
| Interferon-alpha | 2 | 2007 | 194 | 0.030 |
Why?
| Enzyme Inhibitors | 1 | 2019 | 832 | 0.030 |
Why?
| beta Catenin | 1 | 2017 | 223 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2021 | 842 | 0.030 |
Why?
| Osteogenesis | 1 | 2017 | 197 | 0.030 |
Why?
| Caspase 8 | 2 | 2005 | 48 | 0.030 |
Why?
| Minichromosome Maintenance Proteins | 1 | 2014 | 4 | 0.030 |
Why?
| Fas Ligand Protein | 2 | 2005 | 59 | 0.030 |
Why?
| DNA, Ribosomal | 1 | 2014 | 82 | 0.030 |
Why?
| Down-Regulation | 1 | 2017 | 642 | 0.030 |
Why?
| Thrombopoietin | 1 | 2013 | 5 | 0.030 |
Why?
| Chemokine CCL3 | 1 | 2013 | 17 | 0.030 |
Why?
| Cell Transdifferentiation | 1 | 2013 | 32 | 0.030 |
Why?
| Protein Binding | 1 | 2018 | 2120 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2020 | 2282 | 0.020 |
Why?
| Precursor Cells, B-Lymphoid | 1 | 2011 | 36 | 0.020 |
Why?
| Feedback, Physiological | 1 | 2011 | 75 | 0.020 |
Why?
| Fusion Proteins, bcr-abl | 1 | 2011 | 63 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2013 | 465 | 0.020 |
Why?
| Phenotype | 1 | 2019 | 3084 | 0.020 |
Why?
| Pregnancy | 1 | 2022 | 6301 | 0.020 |
Why?
| Hematologic Neoplasms | 1 | 2011 | 142 | 0.020 |
Why?
| Histones | 1 | 2014 | 589 | 0.020 |
Why?
| Jurkat Cells | 1 | 2008 | 136 | 0.020 |
Why?
| Interleukins | 1 | 2010 | 247 | 0.020 |
Why?
| Risk Factors | 1 | 2022 | 9865 | 0.020 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2007 | 20 | 0.020 |
Why?
| Toll-Like Receptor 3 | 1 | 2007 | 29 | 0.020 |
Why?
| Ubiquitin | 1 | 2007 | 63 | 0.020 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 239 | 0.020 |
Why?
| Interleukin-1alpha | 1 | 2007 | 56 | 0.020 |
Why?
| Neutrophil Activation | 1 | 2007 | 79 | 0.020 |
Why?
| STAT1 Transcription Factor | 1 | 2007 | 70 | 0.020 |
Why?
| Ubiquitination | 1 | 2007 | 99 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2007 | 211 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2007 | 142 | 0.020 |
Why?
| Haplotypes | 1 | 2008 | 473 | 0.020 |
Why?
| Sendai virus | 1 | 2006 | 16 | 0.020 |
Why?
| Interferon-gamma | 1 | 2010 | 766 | 0.020 |
Why?
| Intracellular Fluid | 1 | 2006 | 27 | 0.020 |
Why?
| DNA Primers | 1 | 2007 | 523 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 431 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2017 | 5083 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2007 | 586 | 0.020 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 2 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2007 | 842 | 0.020 |
Why?
| Cycloheximide | 1 | 2005 | 55 | 0.010 |
Why?
| Dactinomycin | 1 | 2005 | 30 | 0.010 |
Why?
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 25 | 0.010 |
Why?
| Toll-Like Receptor 2 | 1 | 2006 | 125 | 0.010 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2005 | 50 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2014 | 2549 | 0.010 |
Why?
| Chemokines | 1 | 2006 | 229 | 0.010 |
Why?
| Caspase Inhibitors | 1 | 2005 | 83 | 0.010 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 29 | 0.010 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 43 | 0.010 |
Why?
| Mice, Inbred C3H | 1 | 2005 | 280 | 0.010 |
Why?
| Dendritic Cells | 1 | 2007 | 484 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2007 | 2060 | 0.010 |
Why?
| Phosphorylation | 1 | 2007 | 1709 | 0.010 |
Why?
| Oligopeptides | 1 | 2005 | 258 | 0.010 |
Why?
| Enzyme Activation | 1 | 2005 | 817 | 0.010 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2003 | 197 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2007 | 2854 | 0.010 |
Why?
| MAP Kinase Signaling System | 1 | 2004 | 311 | 0.010 |
Why?
| Alleles | 1 | 2005 | 848 | 0.010 |
Why?
| Child | 1 | 2020 | 20961 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2005 | 3185 | 0.010 |
Why?
| Middle Aged | 1 | 2017 | 31322 | 0.010 |
Why?
|
|
Pietras's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|